Community Nursing Practicum
“2024 Summer COVID19 Surge: A Community Health Nursing Education Project”
CNN Coverage Article
Covid-19 levels have been rising in the United States for weeks as new variants drive what’s become an annual summer surge.
Covid-19 surveillance has been scaled back significantly since the US public health emergency ended more than a year ago — individual cases are no longer counted, and severe outcomes are based on representative samples of the population — but the data that is available is showing a consistent upward trend.
Infections are probably growing in at least 38 states, according to data Links to an external site. from the US Centers for Disease Control and Prevention. Wastewater surveillance suggests that viral activity is still relatively low, but hospitalizations and deaths are also ticking up.
Covid-19 levels are especially high in the West, where viral levels are back to what they were in February, and in the South, according to the CDC.
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says. Links to an external site.
“The virus tends to replicate well and to stay alive in an environment with warm and moist conditions. That fits with what we’re seeing,” said Dr. Robert Hopkins, medical director of the National Foundation for Infectious Diseases, a nonprofit public health organization. “The South and the West are steamy and hot right now.”
The summer bump has become a familiar seasonal pattern, but experts warn that the coronavirus can still be quite unpredictable.
“I think it’s still a bit early to say what the pattern is,” Hopkins said. “A large portion of the population has had some exposure to the virus, the peaks have been a little bit less high, and we have tended to see a summer bump as well as a winter increase. But whether that pattern is going to continue or whether it will become an all-year-round disease or whether it will stay in one particular time — I think it’s a little early to say.”
Data from WastewaterSCAN Links to an external site., a nationwide sewage surveillance network based at Stanford University in partnership with Emory University, suggests that this summer wave started weeks earlier than last summer’s wave and has reached levels similar to last summer’s peak.
“It remains to be seen if this will be a peak level for this surge,” said Dr. Marlene Wolfe, assistant professor of environmental health at Emory and program director for WastewaterSCAN.
“We are always trying to unpack what is potential seasonality with Covid and also what are the impacts of new variants that may be coming through that drive these surges that we see more regularly, more frequently than we do for influenza and RSV,”
A summer wave of Covid-19 has arrived in the US | CNN Links to an external site.
Epidemiology Emergency Preparedness Center for Disease Control COVID-19 Vaccination Plan Georgia-Interim Updated 2.19.21 (Team)_formatted.pdf
Treatments and Medications Links to an external site.
Antiviral medications are available to treat mild to moderate COVID-19. Start treatment as soon as you develop symptoms. Links to an external site.
Coronavirus Disease 2019 (COVID-19) | CDC Links to an external site.
COVID-19 Treatment and Preventive Medication
Updated Apr. 16, 2024
Español Links to an external site.
Print Links to an external site.
This page provides a treatment overview for the general public.
For healthcare providers: Interim Clinical Considerations for COVID-19 Treatment and Pre-exposure Prophylaxis Links to an external site. in Outpatients
On This Page
COVID-19 Treatments Links to an external site.
COVID-19 Preventive Medication (pre-exposure prophylaxis) Links to an external site.
What You Need to Know
If you have COVID-19 and are more likely to get very sick Links to an external site. from COVID-19, treatment is available Links to an external site. that can reduce your risk of hospitalization and death.
Don’t delay: Treatments must be started within 5-7 days after you first develop symptoms.
Other medications can help reduce symptoms and help you manage your illness.
The Treatment Locator (hhs.gov) Links to an external site. can help you find a location that offers testing and treatment or a pharmacy where you can fill your prescription.
Learn more about what to do if you are sick Links to an external site..
Treating COVID-19
Most people with COVID-19 have mild illness and can recover at home. You can treat symptoms Links to an external site. with over-the-counter medicines, such as acetaminophen or ibuprofen, to help feel better.
If you have COVID-19 and are more likely to get very sick from COVID-19, treatments are available Links to an external site. that can reduce your chances of being hospitalized or dying from the disease. Medications to treat COVID-19 must be prescribed by a healthcare provider or pharmacist and started within 5–7 days after symptoms appear. Contact a healthcare provider right away to determine if you are eligible for treatment, even if your symptoms are currently mild.
Don’t delay: Treatment must be started within 5–7 days of when you first develop symptoms.
People who are more likely to get very sick include:
Older adults Links to an external site.(especially those ages 65 years or older, with risk further increasing with advancing age),
People who are unvaccinated or are not up to date Links to an external site.on their COVID-19 vaccinations,
People with certain medical conditions Links to an external site., such as chronic lung disease, heart disease, or a weakened immune system.
Staying up to date with your COVID-19 vaccinations makes you much less likely to get very ill, be hospitalized, or even die from COVID-19. Treatments can further reduce the risk for COVID-19 hospitalization and death among vaccinated people, especially those at higher risk for severe illness. A healthcare provider will help decide whether treatment is right for you. Check with your healthcare provider or pharmacist if you are taking other medications to make sure the COVID-19 treatments can be safely taken at the same time.
Treatments
FDA has authorized or approved several antiviral medications used to treat mild to moderate COVID-19 in people who are more likely to get very sick.
Antiviral treatments for COVID-19 Links to an external site.target specific parts of the virus to stop it from multiplying in the body once someone is infected, helping to prevent severe illness and death.
The Infectious Diseases Society of America provides Guidelines on the Treatment and Management of Patients with COVID-19 Links to an external site.for healthcare providers to help them work with their patients and determine the best treatment options for them. Several treatment options are available for treating COVID-19. They do not treat other common respiratory viruses such as flu. COVID-19 treatment options include:
Treatment
Who (Among persons who are at high risk of getting sick)
When
How
Nirmatrelvir with Ritonavir (Paxlovid) Links to an external site.
Antiviral
Adults; children ages 12 years and older
Start as soon as possible; must begin within 5 days of when symptoms start
Taken at home by mouth (orally)
Remdesivir (Veklury) Links to an external site.
Antiviral
Adults and children
Start as soon as possible; must begin within 7 days of when symptoms start
Intravenous (IV) infusions at a healthcare facility for 3 consecutive days
Molnupiravir (Lagevrio) Links to an external site.
Antiviral
Adults
Start as soon as possible; must begin within 5 days of when symptoms start
Taken at home by mouth (orally)
Some treatments might have side effects or interact with other medications you are taking. If you don’t have a healthcare provider, visit a Test to Treat location Links to an external site. or contact your local community health center or health department.
If you are hospitalized, your healthcare provider might use other types of treatments, depending on how sick you are. These could include medications to better recognize and respond to the virus, treat the infection, reduce an overactive immune response, or treat COVID-19 complications.
If you have a weakened immune system, have received antiviral treatment, and continue to experience COVID-19 symptoms, your healthcare provider may recommend additional treatment, including convalescent plasma.
COVID-19 Rebound
COVID-19 rebound is a return of symptoms or a new positive test 3-7 days after recovering from the initial illness, or after having tested negative for SARS-CoV-2, the virus that causes COVID-19. People may experience rebound whether they received COVID-19 antiviral treatment or not. Rebound symptoms are typically mild.
Studies suggest there is no increased risk of severe COVID-19 illness in people who experience COVID-19 rebound after antiviral treatment.
The benefits of COVID-19 treatment outweigh the risk of rebound if you are at high risk for severe COVID-19. Talk to your healthcare provider if you think you may have rebound. If you don’t have a healthcare provider, visit a Test to Treat location Links to an external site. or contact your local community health center or health department.
Watch ASL Video:
Get Treatment for COVID-19 Links to an external site.
Treatment Locator
Click the button below or call 1-800-232-0233 (TTY 1-888-720-7489) to find a location that offers testing and treatment or a pharmacy where you can fill your prescription.
View Locations Links to an external site.
COVID-19 oral antiviral treatments Paxlovid and Lagevrio are available on the commercial market. Patient assistance programs Links to an external site. are available to people who are underinsured, uninsured, or on Medicaid or Medicare to lower their out-of-pocket costs. You should enroll in these programs to learn if you can receive assistance for specific medications, regardless of your insurance status. Call ahead to your healthcare provider and insurer to confirm coverage eligibility.
The right medications for COVID-19 Links to an external site. can help. But people have been seriously harmed and even died after taking products not approved or authorized for use to treat or prevent COVID-19, even products approved or prescribed for other uses. Talk to your healthcare provider about taking medications to treat COVID-19.
Preventing COVID-19
COVID-19 vaccines
COVID-19 vaccines available in the United States effectively protect people from getting seriously ill, being hospitalized, and even dying. As with vaccines for other diseases, you are protected best when you stay up to date Links to an external site.. People who are moderately or severely immunocompromised may get additional doses of updated COVID-19 vaccines. People aged 65 and older should receive 1 additional dose of an updated COVID-19 vaccine. CDC recommends that everyone who is eligible stay up to date on their COVID-19 vaccines Links to an external site..
Pre-exposure Prophylaxis (Medication for Preventing COVID-19)
FDA has authorized Links to an external site. a preventive monoclonal antibody for people who are moderately or severely immunocompromised Links to an external site., ages 12 years and older, and weighing at least 88 pounds. In addition to vaccination, Pemivibart (Pemgarda™) Links to an external site. may provide another layer of protection against COVID-19 and can be given at least 2 weeks after receiving a COVID-19 vaccine.
A healthcare provider gives Pemgarda as a single intravenous infusion over 60 minutes at a doctor’s office or healthcare facility. If continued protection is needed, additional doses should be administered every 3 months.
People who are privately insured or have Medicare part B may receive Pemgarda for free. Talk to your healthcare provider to see if Pemgarda is right for you.
Articles to Read:
1. The Effect of COVID-19 on Education
Jacob Hoofman Links to an external site., MS2a and Elizabeth Secord Links to an external site., MDb,∗ The Effect of COVID-19 on Education – PMC (nih.gov) Links to an external site.
2. A Literature Review on Impact of COVID-19 Pandemic on Teaching and Learning
Sumitra Pokhrel Links to an external site. *********************** and Roshan Chhetri Links to an external site.View all authors and affiliations Links to an external site.
Volume 8, Issue 1 Links to an external site.
https://doi.org/10.1177/2347631120983481 Links to an external site.
A Literature Review on Impact of COVID-19 Pandemic on Teaching and Learning – Sumitra Pokhrel, Roshan Chhetri, 2021 (sagepub.com) Links to an external site.
New Data Show How the Pandemic Affected Learning Across Whole Communities
Most comprehensive picture yet of COVID’s unequal impacts — and the urgency to expand learning opportunities May 2023
New Data Show How the Pandemic Affected Learning Across Whole Communities | Harvard Graduate School of Education Links to an external site.
ASSIGNMENT GUIDE
Each group of students is to synthesize a PowerPoint presentation on the basic key elements of each objective assigned per group. One objective per group. Group1, Group II and Group III objectives.
Each group presentation will have four slides of content to the context of each group objective.
Assessment, Diagnostic, Planning, and Evaluation must be threaded in each presentation
Remember each group will have one objective to present with four slides.
Hint: The program learning outcomes are the guide to the group presentation content.
All references for each presentation will be cited in APA format in the Final Reference Slide for Each Group Presentation.
Community Health Project Mission
Preparedness is a core value of the Community Health Program.
Increasing epidemiologic awareness to respond to sentinel or population health events is primordial for all in nursing education.
To increase readiness through training, planning and exercises are key focus areas to tackle.
Community Health Project Objectives: Coronavirus Disease 2019 (COVID-19) | CDC Links to an external site.
To provide adequate information on COVID19 as an update to the understanding of the disease and potential treatment implications. Group I
Elements: Adequate information of COVID19 Surge and treatment Implications from CDC, NIH, World Health Organization
Slide One: COVID19 Epidemiology.
Slide Two: Understanding the Disease Clinical Presentation.
Slide Three: Recent Treatment and Vaccine Implications.
Slide Four: Summer 2024 Clinical Variant Surge
Reference Slide: APA Format from Pyramid of Empirical Evidence from Best Practice Guideline to Expert Opinion. Focus Must Be on the Problem and or Population of Focus.
Assessment, Diagnostic, Planning, and Evaluation must be threaded
A pre- and post- test will have to be written.
Ensure that facilitating effective information via resources are in place for healthcare professionals in academic education and practice for high risk populations. Group II
Elements: How to facilitate effective information for educators and healthcare professionals in population health? How and who will receive the information in context and content?
Slide One: Clinical Pathway Algorithm CDC Standards.
Slide Two: Information Via Resources.
Slide Three: Educators and Healthcare Professionals Standards for Community Health.
Slide Four: Target Audience and Community Resources Health Promotion for High risk Groups.
Reference Slide: APA Format from Pyramid of Empirical Evidence from Best Practice Guideline to Expert Opinion. Focus Must Be on the Problem and or Population of Focus.
Assessment, Diagnostic, Planning, and Evaluation must be threaded.
A pre- and post- test will have to be written.
Promote quality improvement and assurance improving awareness to disease management and healthcare information. Group III
Elements: The information delivered to educators and healthcare professionals to maintain competency in evidence-based practice. What would be the forum to maintain open communication for adequate information updates on policies, procedures and protocols?
Slide One: Improving Population Awareness to Disease Management.
Slide Two: Maintaining Competency in Evidence-Based Health Practice
Slide Three: Best Forum in Academic and Healthcare Practice to Promote Awareness: Unit Based, Divisional and or Organizational: Lunch and Learns, Education and Development, Clinical Grand Rounds.
Slide Four: Recommendations for Dissemination of the Evidence Year Round
Reference Slide: APA Format from Pyramid of Empirical Evidence from Best Practice Guideline to Expert Opinion. Focus Must Be on the Problem and or Population of Focus.
Assessment, Diagnostic, Planning, and Evaluation must be threaded.
A pre- and post- test will have to be written.
Community Education Program Learning Outcomes
The program participants will be able to identify information on COVID19 as an update for Summer 2024 with understanding of the present disease and potential treatment implications for positive outcomes.
The program participants will be able to access COVID19 information via resources for healthcare professionals in academic education and practice.
The program participants will be able to maintain an information forum to preserve open communication for adequate information updates on policies, procedures and protocols?
Assignment Rubric
NAME: COURSE: DATE:
COMMUNITY PROJECT TITLE RUBRIC: “2024 Summer COVID19 Surge: A Community Health Nursing Education Project”
Assessment, Diagnostic, Planning, and Evaluation must be threaded throughout project
100 % 88% 77% 60%
Criteria
4
(Exceeds Expectations)
3
(Meets Expectations)
2
(Approaching Expectations
1
(Does Not Meet
Expectations)
Weight
Assessment
□ Assessment of the Covid19 health concern and Vaccine Implications was explained in detail including a thorough description of the community setting and population.
□ Assessment of Covid19 was explained and Vaccine Implications in some detail with moderate description of the community setting and population.
□ Assessment of Covid19 and Vaccine Implications was explained in limited detail with a marginal description of the community and population.
□ Assessment of Covid19 and Vaccine Implications was limited with poor understanding of the community.
10 points
Supportive Data
□ Correctly identifies two Covid19 appropriate references from the community to support identified concern. Correctly sites references using APA
Format.
□Correctly identifies one appropriate reference of Covid19from community to support identified concern. Correctly sites reference using APA
Format.
□ Correctly identifies Covid19 resources. References not cited.
□ No Covid19 community references are identified.
10 points
Evidence of Planning
□ Shows steps on how you planned to assist with Covid19 health concern for the community thoroughly
explained.
□ Shows steps on how you planned to assist with Covid19 health concern for the community is
moderately explained.
□ Marginal description of planning Covid19
□ Planning of Covid19 is not explained.
10 points
Supportive Literature
□ Four appropriate EBP literature reviews are included (within the last five years). Properly
cited using APA Format.
□ Three appropriate EBP literature reviews are included (within the last five years). Properly
cited using APA Format.
□ Two appropriate EBP literature reviews are included (within the last five years). Properly
cited using APA Format.
□ No EBP literature reviews are included.
10 points
Evaluation
□ Thorough description of project
evaluation is done with
□ Moderate description of project
evaluation is done with
□ Vague description of project evaluation is done with
□ No description of
evaluation or goals
10 points
Page 3 of 5
Criteria
4
(Exceeds Expectations)
3
(Meets Expectations)
2
(Approaching Expectations
1
(Does Not Meet
Expectations)
Weight
two measurable goals identified.
one measurable goal identified.
goals identified, not measurable.
included.
Project Description
□ Thoroughly describes the Covid19 project to class including materials developed for your project. Meets the requirement of being at the 5th grade reading level if applicable.
Provides thorough explanation of benefits for the community.
□ Moderate description of Covid19 project to class including materials developed for your project. Meets the requirement of being at the 5th grade reading level if applicable with moderate explanation of benefits for the community.
□ Vague description of Covid19project to class. Meets the requirement of being at the 5th grade reading level with a vague explanation of benefits for the community.
□ Covid19 Project is not described.
20 points
Learning Theory/Health Promotion Model
□ Identifies two Covid19 references, either a clinical theory or health promotion model.
□ Describes how this education forum was used in your project.
□ Correctly citing references using APA
format.
□ Identifies one Covid19 reference, either a clinical theory or health promotion model.
□ Described somewhat how this was used in your project.
□ Correctly citing references using APA format.
□ Identifies Covid19 references, either a clinical theory or health promotion model.
□ No description on how used in your project.
□ References not cited.
□ No Covid19 Clinical Theory or Health Promotion model or
□ vaguely discussed with
□ No references cited.
20 points
Community Agency
□ Community agency identified with thorough description provided CDC, NIH. CMS Discussion of benefits or lack of benefits the agency provides.
□ Described how you
□ Community agency CDC, NIH, CMS identified with moderate description provided. Discussion of benefits or lack of benefits the agency provides.
□ Vague description of
□ Community agency identified with vague description provided, CDC, NIH, CMS. Benefits or lack of benefits not included.
□ No description how you assisted them.
□ No name of person
□ Community agency not included. CDC, NIH, CMS.
10 points
Page 4 of 5
Total Possible Points:
/72= %
100 Points
